Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy
IntroductionX-linked hypophosphatemia (XLH) is caused by an inactivating mutation in the phosphate-regulating endopeptidase X-linked (PHEX) gene whose defective product fails to control phosphatonin fibroblast growth factor 23 (FGF23) serum levels. Although elevated FGF23 levels have been linked wit...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2024-05-01
|
| Serier: | Frontiers in Endocrinology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1400273/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
